XNAS 14 Jul, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Scott A. Greenwell | President, PharMerica | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.25 per share. | 20 Jun 2026 | 2,487 | 34,372 | - | 66.3 | 164,764 | Common Stock |
| Nigam H. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 4,013 | 4,013 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 05 Jun 2026 | 130,000 | 1,324,503 | - | 6.4 | 828,100 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 130,000 | 404,676 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 130,000 | 1,166,064 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 58.75 per share. | 05 Jun 2026 | 130,000 | 0 | - | 58.8 | 7,637,500 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 05 Jun 2026 | 130,000 | 130,000 | - | 6.4 | 828,100 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 58.75 per share. | 05 Jun 2026 | 130,000 | 1,194,503 | - | 58.8 | 7,637,500 | Common Stock |
| Lisa Nalley | See Remarks | Sale of securities on an exchange or to another person at price $ 58.75 per share. | 05 Jun 2026 | 35,000 | 131,948 | - | 58.8 | 2,056,250 | Common Stock |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 35,000 | 41,909 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 05 Jun 2026 | 35,000 | 166,948 | - | 6.4 | 222,950 | Common Stock |
| Jennifer Phipps | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 05 Jun 2026 | 35,000 | 285,224 | - | 6.4 | 222,950 | Common Stock |
| Jennifer Phipps | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 58.75 per share. | 05 Jun 2026 | 35,000 | 250,224 | - | 58.8 | 2,056,250 | Common Stock |
| Jennifer Phipps | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 35,000 | 55,708 | - | - | Stock Options (Right to Buy) | |
| Olivia F. Kirtley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2026 | 4,983 | 36,997 | - | 0 | Common Stock | |
| Timothy A. Wicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2026 | 4,983 | 25,504 | - | 0 | Common Stock | |
| Steven B. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2026 | 4,983 | 23,106 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.16 per share. | 25 Apr 2026 | 16,222 | 1,194,503 | - | 48.2 | 781,252 | Common Stock |
| Robert Barnes | President, Community Living | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.54 per share. | 30 Mar 2026 | 6,748 | 25,549 | - | 41.5 | 280,312 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Mar 2026 | 192,704 | 192,704 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Mar 2026 | 192,704 | 192,704 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Mar 2026 | 192,704 | 0 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Mar 2026 | 180,753 | 447,355 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Mar 2026 | 180,753 | 180,753 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Mar 2026 | 192,704 | 254,651 | - | - | Stock Options (Right to Buy) | |
| Scott A. Greenwell | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 49,073 | 49,073 | - | - | Stock Options (Right to Buy) | |
| Scott A. Greenwell | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 20,020 | 36,859 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 04 Mar 2026 | 220,000 | 1,243,880 | - | 6.4 | 1,401,400 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 186,845 | 1,210,725 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 955,823 | 1,516,064 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 220,000 | 1,296,064 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 458,008 | 458,008 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 41.15 per share. | 04 Mar 2026 | 220,000 | 1,023,880 | - | 41.2 | 9,053,000 | Common Stock |
| Robert Barnes | President, Community Living | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 2,944 | 11,776 | - | - | Stock Options (Right to Buy) | |
| Robert Barnes | President, Community Living | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 35,331 | 113,718 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Sale of securities on an exchange or to another person at price $ 41.15 per share. | 04 Mar 2026 | 30,000 | 110,594 | - | 41.2 | 1,234,500 | Common Stock |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 21,354 | 131,948 | - | 0 | Common Stock | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 3,925 | 15,702 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 52,344 | 52,344 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 30,000 | 76,909 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 35,331 | 106,909 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 04 Mar 2026 | 30,000 | 140,594 | - | 6.4 | 191,100 | Common Stock |
| Jennifer Phipps | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 53,384 | 250,224 | - | 0 | Common Stock | |
| Jennifer Phipps | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 04 Mar 2026 | 35,000 | 231,840 | - | 6.4 | 222,950 | Common Stock |
| Jennifer Phipps | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.15 per share. | 04 Mar 2026 | 35,000 | 196,840 | - | 41.2 | 1,440,250 | Common Stock |
| Jennifer Phipps | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 35,331 | 125,708 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 5,888 | 23,543 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 35,000 | 90,708 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 130,860 | 130,860 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.64 per share. | 25 Jan 2026 | 49,304 | 1,023,880 | - | 39.6 | 1,954,411 | Common Stock |
| Robert Barnes | President, Community Living | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.64 per share. | 25 Jan 2026 | 6,972 | 32,297 | - | 39.6 | 276,370 | Common Stock |
| Lisa Nalley | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.64 per share. | 25 Jan 2026 | 20,556 | 110,594 | - | 39.6 | 814,840 | Common Stock |
| Jennifer Phipps | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.64 per share. | 25 Jan 2026 | 33,190 | 196,840 | - | 39.6 | 1,315,652 | Common Stock |
| Steven B. Miller | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.68 per share. | 05 Nov 2025 | 4,497 | 18,123 | - | 32.7 | 146,962 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.53 per share. | 25 Oct 2025 | 49,796 | 1,082,134 | - | 33.5 | 1,669,660 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.53 per share. | 25 Oct 2025 | 58,746 | 1,073,184 | - | 33.5 | 1,969,753 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 22 Oct 2025 | 235,000 | 1,366,930 | - | 6.4 | 1,496,950 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2025 | 235,000 | 560,241 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 28.78 per share. | 22 Oct 2025 | 235,000 | 1,131,930 | - | 28.8 | 6,763,770 | Common Stock |
| Lisa Nalley | See Remarks | Sale of securities on an exchange or to another person at price $ 28.78 per share. | 22 Oct 2025 | 20,000 | 131,150 | - | 28.8 | 575,640 | Common Stock |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2025 | 20,000 | 71,578 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 22 Oct 2025 | 20,000 | 151,150 | - | 6.4 | 127,400 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.53 per share. | 25 Jul 2025 | 52,203 | 1,131,930 | - | 20.5 | 1,071,728 | Common Stock |
| Scott A. Greenwell | President, PharMerica | 20 Jun 2025 | 16,839 | 16,839 | - | 0 | Common Stock | ||
| Scott A. Greenwell | President, PharMerica | 20 Jun 2025 | 35,920 | 35,920 | - | - | Stock Options (Right to Buy) | ||
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 531,840 | 795,241 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 12 Jun 2025 | 531,840 | 1,715,973 | - | 6.4 | 3,387,821 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 12 Jun 2025 | 531,840 | 1,184,133 | - | 21.8 | 11,567,520 | Common Stock |
| Bob Barnes | President, Community Living | 12 Jun 2025 | 30,730 | 39,269 | - | 21.8 | 668,378 | Common Stock | |
| Bob Barnes | President, Community Living | 12 Jun 2025 | 27,606 | 69,999 | - | 6.4 | 175,850 | Common Stock | |
| Bob Barnes | President, Community Living | 12 Jun 2025 | 27,606 | 78,387 | - | - | Stock Options (Right to Buy) | ||
| Mike McMaude | See Remarks | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 12 Jun 2025 | 119,298 | 207,590 | - | 21.8 | 2,594,732 | Common Stock |
| Lisa Nalley | See Remarks | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 12 Jun 2025 | 14,415 | 131,150 | - | 21.7 | 313,526 | Common Stock |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 14,415 | 91,578 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 12 Jun 2025 | 14,415 | 145,565 | - | 6.4 | 91,824 | Common Stock |
| Jennifer Phipps | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 15,616 | 90,377 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 12 Jun 2025 | 15,616 | 245,646 | - | 6.4 | 99,474 | Common Stock |
| Jennifer Phipps | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 12 Jun 2025 | 15,616 | 230,030 | - | 21.8 | 339,648 | Common Stock |
| Olivia F. Kirtley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 11,912 | 32,014 | - | 0 | Common Stock | |
| Timothy A. Wicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 11,912 | 20,521 | - | 0 | Common Stock | |
| Steven B. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 11,912 | 22,620 | - | 0 | Common Stock | |
| Timothy A. Wicks | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.87 per share. | 03 May 2025 | 7,044 | 8,609 | - | 20.9 | 147,008 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.55 per share. | 25 Apr 2025 | 48,887 | 1,184,133 | - | 16.6 | 809,080 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 733,496 | 733,496 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 345,424 | 1,233,020 | - | 0 | Common Stock | |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 23,029 | 75,401 | - | 0 | Common Stock | |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 48,900 | 48,900 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 46,057 | 131,150 | - | 0 | Common Stock | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 97,800 | 97,800 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 86,356 | 230,030 | - | 0 | Common Stock | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 183,374 | 183,374 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 44,362 | 887,596 | - | 22.8 | 1,012,341 | Common Stock |
| Jim Mattingly | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 12,115 | 122,665 | - | 22.8 | 276,464 | Common Stock |
| Jennifer Yowler | President, PharMerica | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 8,508 | 52,372 | - | 22.8 | 194,153 | Common Stock |
| Bob Barnes | President, Community Living | 25 Jan 2025 | 7,351 | 42,393 | - | 22.8 | 167,750 | Common Stock | |
| Mike McMaude | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 7,202 | 326,888 | - | 22.8 | 164,350 | Common Stock |
| Lisa Nalley | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 14,501 | 85,093 | - | 22.8 | 330,913 | Common Stock |
| Jennifer Phipps | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 21,944 | 143,674 | - | 22.8 | 500,762 | Common Stock |
| Steven B. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 10,708 | 10,708 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.50 per share. | 25 Oct 2024 | 36,740 | 931,958 | - | 15.5 | 569,470 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.09 per share. | 25 Jul 2024 | 20,198 | 968,698 | - | 12.1 | 244,194 | Common Stock |
| Matthew D’Ambrosio | Director | Purchase of securities on an exchange or from another person at price $ 11.46 per share. | 20 May 2024 | 1,000 | 1,000 | - | 11.5 | 11,461 | Common Stock |
| Olivia F. Kirtley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 4,449 | 20,102 | - | 0 | Common Stock | |
| Olivia F. Kirtley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 15,653 | 15,653 | - | 0 | Common Stock | |
| Timothy A. Wicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 15,653 | 15,653 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.41 per share. | 25 Apr 2024 | 36,740 | 988,896 | - | 10.4 | 382,463 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 8.09 per share. | 15 Mar 2024 | 18,400 | 369,763 | - | 8.1 | 148,856 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 8.09 per share. | 15 Mar 2024 | 18,400 | 1,025,636 | - | 8.1 | 148,856 | Common Stock |
| Jim Mattingly | See Remarks | 15 Mar 2024 | 6,080 | 134,780 | - | 8.3 | 50,221 | Common Stock | |
| Jennifer Yowler | President, PharMerica | Purchase of securities on an exchange or from another person at price $ 8.21 per share. | 15 Mar 2024 | 3,000 | 60,880 | - | 8.2 | 24,630 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 8.12 per share. | 14 Mar 2024 | 37,405 | 1,007,236 | - | 8.1 | 303,729 | Common Stock |
| Jim Mattingly | See Remarks | 14 Mar 2024 | 12,280 | 128,700 | - | 8.2 | 100,450 | Common Stock | |
| Jennifer Phipps | Chief Accounting Officer | Purchase of securities on an exchange or from another person at price $ 8.14 per share. | 14 Mar 2024 | 12,300 | 165,618 | - | 8.1 | 100,122 | Common Stock |
| Steven S. Reed | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 19,837 | 19,837 | - | - | Stock Options (Right to Buy) | |
| Steven S. Reed | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 54,658 | 93,914 | - | 0 | Common Stock | |
| Steven S. Reed | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 60,847 | 182,543 | - | - | Stock Options (Right to Buy) | |
| Jim Mattingly | See Remarks | 25 Jan 2024 | 184,506 | 553,520 | - | - | Stock Options (Right to Buy) | ||
| Jim Mattingly | See Remarks | 25 Jan 2024 | 77,164 | 116,420 | - | 0 | Common Stock | ||
| Jim Mattingly | See Remarks | 25 Jan 2024 | 28,005 | 28,005 | - | - | Stock Options (Right to Buy) | ||
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 17,665 | 52,996 | - | - | Stock Options (Right to Buy) | |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 17,665 | 52,996 | - | - | Stock Options (Right to Buy) | |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 21,004 | 21,004 | - | - | Stock Options (Right to Buy) | |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 57,880 | 57,880 | - | 0 | Common Stock | |
| Bob Barnes | President, Community Living | 25 Jan 2024 | 2,944 | 8,832 | - | - | Stock Options (Right to Buy) | ||
| Bob Barnes | President, Community Living | 25 Jan 2024 | 46,620 | 49,744 | - | 0 | Common Stock | ||
| Bob Barnes | President, Community Living | 25 Jan 2024 | 35,331 | 105,993 | - | - | Stock Options (Right to Buy) | ||
| Bob Barnes | President, Community Living | 25 Jan 2024 | 16,919 | 16,919 | - | - | Stock Options (Right to Buy) | ||
| Mike McMaude | See Remarks | 25 Jan 2024 | 18,670 | 18,670 | - | - | Stock Options (Right to Buy) | ||
| Mike McMaude | See Remarks | 25 Jan 2024 | 51,442 | 334,090 | - | 0 | Common Stock | ||
| Mike McMaude | See Remarks | 25 Jan 2024 | 33,349 | 103,048 | - | - | Stock Options (Right to Buy) | ||
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 96,454 | 99,594 | - | 0 | Common Stock | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 3,925 | 11,777 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 35,006 | 35,006 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 35,331 | 105,993 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 5,888 | 17,655 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 35,331 | 105,993 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 144,682 | 153,318 | - | 0 | Common Stock | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 52,509 | 52,509 | - | - | Stock Options (Right to Buy) |